Gotowa bibliografia na temat „Anti diabetic drugs”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Anti diabetic drugs”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Anti diabetic drugs"

1

Ulfa, Ridha, Syarifah NYRS Assegaf, and Mistika Zakia. "PEDULI PENYAKIT TIDAK MENULAR DENGAN SKRINING KESEHATAN, BEDAH BUKU DAN PENYULUHAN PENGGUNAAN OBAT ANTI DIABETIK, OBAT HIPERURISEMIA DAN OBAT DISLIPIDEMIA YANG RASIONAL." Medical Dedication (medic) : Jurnal Pengabdian kepada Masyarakat FKIK UNJA 5, no. 1 (2022): 396–402. http://dx.doi.org/10.22437/medicaldedication.v5i1.18681.

Pełny tekst źródła
Streszczenie:
Abstract
 Concerned for non-communicable diseases by health screening, book review and counseling on the rational use of anti-diabetic drugs, hyperuricemia drugs and dyslipidemia drugs. The purpose of this community service is to increase public knowledge about the dangers of Non-Communicable Diseases (NCD), including cardiovascular disease, diabetes mellitus, dyslipidemia, and hyperuricemia. As well as increasing public awareness about the rational use of anti-diabetic drugs, hyperuricemia drugs and dyslipidemia drugs. The methods of this activity are health checks, blood tests, counseli
Style APA, Harvard, Vancouver, ISO itp.
2

Nanda, Oryza Dwi, Bambang Wiryanto, and Erwin Astha Triyono. "Hubungan Kepatuhan Minum Obat Anti Diabetik dengan Regulasi Kadar Gula Darah pada Pasien Perempuan Diabetes Mellitus." Amerta Nutrition 2, no. 4 (2018): 340. http://dx.doi.org/10.20473/amnt.v2i4.2018.340-348.

Pełny tekst źródła
Streszczenie:
Background: Blood glucose level controlling is the important thing for diabetes mellitus treatment. Diabetics patients need to understand the factors which influence blood glucose level such as the compliance of anti-diabetic drug.Objective: Determine the relationship and the risk of between oral anti-diabetic drug consumption adherence and blood glucose level regulation for diabetes mellitus female patients.Method: Case control study design with purposive sampling technique, in order to obtain 26 research samples which consist of two groups, they are case group (unregulated blood glucose) whi
Style APA, Harvard, Vancouver, ISO itp.
3

Walia, Smily, J. S. Dua, and D. N. Prasad. "Herbal Drugs with Anti-Diabetic Potential." Journal of Drug Delivery and Therapeutics 11, no. 6 (2021): 248–56. http://dx.doi.org/10.22270/jddt.v11i6.5051.

Pełny tekst źródła
Streszczenie:
Diabetes mellitus (DM), also known as insulin-dependent diabetes mellitus (IDDM) and non-insulin dependent diabetes mellitus (NIDDM), is a common and serious metabolic condition that affects people all over the world. Traditional herbal plants have been utilized to treat diabetes mellitus all throughout the world. Several herbs have been found to treat and control diabetes among numerous medicines and poly herbal plants; they also have no adverse effects. Diabetes mellitus is a horrible disease that affects people all over the world and is becoming a serious danger to humanity's health. Thus,
Style APA, Harvard, Vancouver, ISO itp.
4

Sasikumar, Amithkumar, and Sheetal S. "Bruns–Garland syndrome precipitated by anti-tuberculous therapy in a patient with type 2 diabetes mellitus." Nepal Journal of Neuroscience 19, no. 1 (2022): 66–67. http://dx.doi.org/10.3126/njn.v19i1.40952.

Pełny tekst źródła
Streszczenie:
India has a high prevalence of tuberculosis as well as diabetes mellitus, and both contribute to a major disease burden. Diabetes mellitus increases the risk of tuberculosis. Patients with diabetes are more prone to develop cavitary lesions than non-diabetics. Tuberculosis can worsen the glycemic status of an individual and anti-tuberculous drugs like Rifampicin can interact with oral anti-diabetic drugs, further worsening the glycemic control. This can result in complications related to diabetes, like diabetic amyotrophy. We hereby report the case of a 69-year-old gentleman with diabetes mell
Style APA, Harvard, Vancouver, ISO itp.
5

Shaha, Kartick Chanda, Sharmin Jahan, Md Ziaur Rahman Mamun, Md Shafiqur Rahman, Farjana Ahmed, and Bhagyashree Karmokar Jyoti. "Prescribing patterns of anti-diabetic drugs among type 2 diabetic patients at a private Medical College Hospital in Mymensingh." Journal of Dhaka National Medical College & Hospital 23, no. 1 (2017): 29–32. https://doi.org/10.3329/jdnmch.v23i1.78063.

Pełny tekst źródła
Streszczenie:
Background: The right choice of anti-diabetic drugs among type 2 diabetic patients carries a vital role. Objective: The aim of the present study was to evaluate the prescribing patterns of anti-diabetic drugs among type 2 diabetic patients at tertiary level teaching hospital in Mymensingh. Methods: A descriptive, cross sectional study was conducted from July 2015 to June 2016 among patients attending at Medicine Outpatient Department of the Community Based Medical College Hospital. Data were collected through the reviewing of the prescriptions and interviewing of the patients. The collected da
Style APA, Harvard, Vancouver, ISO itp.
6

Siddhi, Nigade* Dinesh Ingole Arundhati Kore Jagruti Shelar. "Review On Anti-Diabetic Drug and Treatment." International Journal of Pharmaceutical Sciences 3, no. 6 (2025): 185–95. https://doi.org/10.5281/zenodo.15574490.

Pełny tekst źródła
Streszczenie:
Diabetes is the third leading cause of death in the United States, and is one of the world's major diseases. Diabetes is a metabolic disorder which is mainly characterized by hyperglycemia and arises from defects in insulin action or both. Approximately 2% of the population in India suffer from diabetes. Anti-diabetic drugs lower the levels of sugar in the blood. Most anti-diabetic drugs are administered by mouth. There are different types of anti-diabetic drugs and their selection depends on a number of factors. Treatments include the agents which increase the amount of insulin produced by th
Style APA, Harvard, Vancouver, ISO itp.
7

Singh, Ved Prakash. "An Overview on Anti Diabetic Drugs and Development." Science & Technology Journal 4, no. 2 (2016): 113–23. http://dx.doi.org/10.22232/stj.2016.04.02.05.

Pełny tekst źródła
Streszczenie:
Diabetes mellitus is one of the world’s major diseases and is the third leading cause of death in the United States after heart disease and cancer. In the India, about 2–6% population suffer from diabetes or related complication. Anti-diabetic drugs treat diabetes mellitus by lowering glucose levels in the blood. Mostly anti-diabetic drugs are administered orally except the insulin, exenatide, and pramlintide. There are different types of anti-diabetic drugs, and their selection depends on the nature of the diabetes, age and situation of the person, and many other factors. Treatments include t
Style APA, Harvard, Vancouver, ISO itp.
8

Devkota, HP, A. Adhikari-Devkota, S. Yahara, and P. Basnet. "Anti-oxidative Activity of Nepalese Traditional Anti-diabetic Medicines." Nepal Journal of Science and Technology 14, no. 2 (2014): 151–54. http://dx.doi.org/10.3126/njst.v14i2.10429.

Pełny tekst źródła
Streszczenie:
Chronic overproduction of free radicals in human body has a role in numerous disease states including diabetes. Proper use of antioxidants may help in the prevention and/or treatment of diabetes. For the management of diabetes, a combination of herbal drugs is being practiced traditionally in Nepal. These herbal medicines might have a good correlation to anti-oxidative properties. Anti-oxidative property was evaluated with the methanolic extracts of nineteen common traditional anti-diabetic medicines by 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging method. Among the evaluated herbal
Style APA, Harvard, Vancouver, ISO itp.
9

Kapur, Ajita, Harmeet Singh Rehan, Lalit Kumar Gupta, and Madhur Yadav. "Pattern of anti-diabetic drugs prescribed for type 2 diabetes mellitus patients in a tertiary care hospital of India: an observational study." International Journal of Basic & Clinical Pharmacology 8, no. 7 (2019): 1657. http://dx.doi.org/10.18203/2319-2003.ijbcp20192667.

Pełny tekst źródła
Streszczenie:
Background: Type 2 diabetes mellitus (T2DM) is a leading cause of significant morbidity and mortality in developing countries. Evaluation of anti-diabetic drug use pattern guides the healthcare professionals to identify early signals of irrational prescribing and to plan interventions to optimize the benefits of pharmacotherapy.Methods: Observational descriptive study was conducted on 500 prescriptions of T2DM patients collected from Outpatient department of a tertiary care hospital. Prescriptions were analysed for type, number, generic/brand names, fixed dose combinations (FDCs) of anti-diabe
Style APA, Harvard, Vancouver, ISO itp.
10

Galstyan, Gagik R., Ekaterina A. Shestakova, and Igor A. Sklyanik. "Obesity and type 2 diabetes: can we find a compromised treatment solution?" Diabetes mellitus 20, no. 4 (2017): 270–78. http://dx.doi.org/10.14341/dm8726.

Pełny tekst źródła
Streszczenie:
Type 2 diabetes and obesity are two enormous epidemic diseases of the 21stcentury. Because obesity is a primary risk factor for type 2 diabetes development, patients with diabetes are frequently obese. This comorbidity makes it challenging for these patients to not only compensate diabetes but also bring their weight back to normal. Several anti-diabetic drugs cause weight gain, which augments insulin resistance, and thus demands anti-diabetic treatment intensification. For the treatment, it is crucial to find an anti-diabetic treatment drug that is efficient but does not cause weight gain. In
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Anti diabetic drugs"

1

Hoa, Nguyen Khanh. "Assessment of anti-diabetic effect of Vietnamese herbal drugs /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-585-2/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Lennox, Rachael. "Actions of anti-diabetic drugs on hippocampal dependent cognitive function in obesity and type 2 diabetes." Thesis, Ulster University, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.667766.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Li, Xiaoxiao. "Ranolazine: a Potential Anti-diabetic Drug." Thesis, Virginia Tech, 2012. http://hdl.handle.net/10919/19202.

Pełny tekst źródła
Streszczenie:
Diabetes is a life-long chronic disease that affects more than 24 million Americans. Loss of pancreatic beta-cell mass and function is central to the development of both type 1 (T1D) and type 2 diabetes (T2D). Therefore, preservation or regeneration of functional beta-cell mass is one of the essential strategies to treat diabetes [1]. In my study, I tested if ranolazine, a synthetic compound, has potential to prevent or treat diabetes. Diabetes were induced in mice by giving multiple low-doses of streptozotocin (STZ). Ranolazine was given twice daily via an oral gavage (20 mg/kg) for 5 weeks.
Style APA, Harvard, Vancouver, ISO itp.
4

Hamrén, Bengt. "Safety and Efficacy Modelling in Anti-Diabetic Drug Development." Doctoral thesis, Uppsala University, Division of Pharmacokinetics and Drug Therapy, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-8648.

Pełny tekst źródła
Streszczenie:
<p>A central aim in drug development is to ensure that the new drug is efficacious and safe in the intended patient population.</p><p>Mathematical models describing the pharmacokinetic-pharmacodynamic (PK-PD) properties of a drug are valuable to increase the knowledge about drug effects and disease and can be used to inform decisions. The aim of this thesis was to develop mechanism-based PK-PD-disease models for important safety and efficacy biomarkers used in anti-diabetic drug development. </p><p>Population PK, PK-PD and disease models were developed, based on data from clinical studies in s
Style APA, Harvard, Vancouver, ISO itp.
5

VanderMeulen, Heather. "Potential anti-inflammatory properties of the diabetic drug metformin." Thesis, McGill University, 2014. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=123091.

Pełny tekst źródła
Streszczenie:
Recent studies have unveiled an anti-inflammatory property of the type 2 diabetes drug, metformin. This has been demonstrated by a decreased severity of endotoxin-induced uveitis in mice. Metformin is also shown to reduce airway remodeling and inflammation in murine models of chronic asthma. While the exact mechanism by which metformin exhibits these effects has yet to be elucidated, the biguanide drug appears to interfere with pro-inflammatory NFkB signaling. We wished to examine whether this phenomenon could be replicated in vivo in various mouse models involving both acute and chronic infla
Style APA, Harvard, Vancouver, ISO itp.
6

Ou, Peimian. "Possible mechanisms for oxidative damage in diabetes mellitus and of some anti-diabetes drugs." Thesis, University College London (University of London), 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.243381.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Craythorne, Natalie Louise. "Nanoparticles as potential drug delivery systems for anti-diabetic peptide therapeutics." Thesis, Ulster University, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.650084.

Pełny tekst źródła
Streszczenie:
Exenatide is a potent glucagon-like peptide-1 receptor agonist used in clinical practice for the management of type 2 diabetes. Exenatide is administered subcutaneously twice daily, or once weekly in the form of poly (Iactide-coglycolide) PLGA microspheres. This study investigated the benefit of using encapsulated nanoparticulate exenatide as an intraperitoneal and oral treatment compared to native peptide. To optomise the encapsulation process and determine its suitability to other peptide or protein formulations, ovalbumin and glucose-dependent insulinotrophic polypeptide (GIP) were used. Th
Style APA, Harvard, Vancouver, ISO itp.
8

Algire, Carolyn. "Impact of the anti-diabetic drug metformin on tumor growth «in vivo»." Thesis, McGill University, 2011. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=103469.

Pełny tekst źródła
Streszczenie:
The prevalence of obesity is rapidly increasing in affluent countries and in many urban areas of the developing world. Epidemiologic studies have associated obesity with increased burden of many cancer types but the mechanisms by which obesity induces transformation or promotes neoplastic growth remain to be fully elucidated. Possible mediators include insulin, free fatty acids, increased bio-availability of steroid hormones and inflammation. It is important to gain better understanding of the relationship between these diseases as new insights may provide new opportunities for cancer prevent
Style APA, Harvard, Vancouver, ISO itp.
9

Tam, Teresa. "The effects of Cree anti-diabetic natural health products on drug metabolism and cardiomyocytes." Thesis, University of Ottawa (Canada), 2009. http://hdl.handle.net/10393/28230.

Pełny tekst źródła
Streszczenie:
Seventeen Cree anti-diabetic medicinal plant were investigated for their capacity to cause adverse effects when used as alternative or complementary medicine. Two aspects of safety were studied using their extracts: the ability to affect the contraction rate of neonatal rat cardiomyocytes in vitro to determine if the plants can influence the human heart rate, and the ability to interfere with drug metabolism by inhibiting the cytochrome P450 enzymes in vitro. The results suggest that several Cree plants may cause a harmful effect through different mechanisms. The extracts ofW2, W4, W5, and W9
Style APA, Harvard, Vancouver, ISO itp.
10

Gedawy, Ahmed Abou Bakr Gaber. "Innovative platforms for oral microencapsulation formulation and drug analytical techniques for anti-diabetics." Thesis, Curtin University, 2020. http://hdl.handle.net/20.500.11937/81966.

Pełny tekst źródła
Streszczenie:
This thesis is divided into two main sections. The first section is about developing of silicon-based pharmaceutical platform that was used to encapsulate an anti-diabetic agent (metformin). These developed microcapsules were then characterised in terms of drug content, encapsulation efficiency, flow properties and microscopical examination. The second section is about development and validation of a new HPLC analytical method for the detection and quantification of metformin and two other anti-diabetic agents that belong to sulfonylureas.
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Anti diabetic drugs"

1

Yŏm, Yŏng-il. Chŏnsachʻe pʻŭropʻail ŭl iyong han hang tangnyo chagyong kijŏn kŏmjŭng yŏnʼgu =: Study of the action mechanism of anti-diabetic drugs by transcriptome profiling. Sikpʻum Ŭiyakpʻum Anjŏnchʻŏng, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Canadian Coordinating Office for Health Technology Assessment., ed. Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents. Canadian Coordinating Office for Health Technology Assessment, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Pharm, Boucher Michel B., and Canadian Coordinating Office for Health Technology Assessment., eds. Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents: Systematic review and budget impact analysis. Canadian Coordinating Office for Health Technology Assessment, 2002.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Pharm, Boucher Michel B., and Canadian Coordinating Office for Health Technology Assessment., eds. Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents: Systematic review and budget impact analysis. Canadian Coordinating Office for Health Technology Assessment, 2002.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Medicinal Plants: Promising Future for Health and New Drugs. Taylor & Francis Group, 2018.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Kuroedov, Alexey. Role of protein kinase C[beta] inhibitors and glycogen synthase kinase-3 inhibitors, new anti-diabetic drugs, in preventing atherogenic transformation of monocytes and endothelial activation. 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Li, Jie Jack. Laughing Gas, Viagra, and Lipitor. Oxford University Press, 2006. http://dx.doi.org/10.1093/oso/9780195300994.001.0001.

Pełny tekst źródła
Streszczenie:
The stories behind drug discovery are fascinating, full of human and scientific interest. This is a book on the history of drug discovery that highlights the intellectual splendor of discoverers as well as the human frailty associated them. History is replete with examples of breakthrough medicines that have saved millions of lives. Ether as an anesthetic by Morton; penicillin as an antibiotic by Fleming; and insulin as an anti-diabetic by Banting are just a few examples. The discoverers of these medicines are doubtlessly benefactors to mankind--for instance, without penicillin, 75% of us prob
Style APA, Harvard, Vancouver, ISO itp.
8

Ghani, Usman. Alpha-Glucosidase Inhibitors: Promising Candicates for Anti-Diabetic Drug Discovery. Elsevier, 2019.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Ghani, Usman. Alpha-Glucosidase Inhibitors: Clinically Promising Candidates for Anti-Diabetic Drug Discovery. Elsevier, 2019.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Jones, Roy W. Pharmacological treatment of dementia. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199644957.003.0038.

Pełny tekst źródła
Streszczenie:
This chapter summarises the available clinical evidence for specific pharmacological treatments for dementia with a particular emphasis on practical considerations and realistic expectations of currently available anti-dementia drugs. It covers the treatment of both cognitive and non-cognitive symptoms. The search for specific treatments for dementia has inevitably concentrated on Alzheimer’s disease (AD), partly because it is the commonest cause of dementia and partly because scientific progress has provided more potential therapeutic targets for AD than other dementias. AD is treated with AC
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Anti diabetic drugs"

1

Falcomatà, B., Maurizio Battaglia Parodi, P. Iacono, G. Guarnaccia, and F. Bandello. "Use of Anti-Vascular Endothelial Growth Factor Drugs for Diabetic Macular Edema." In Surgical Retina. S. KARGER AG, 2012. http://dx.doi.org/10.1159/000338155.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Rao, Madhushree M. V., Likith M, Gayathri D S, Ravikumar H, and Hariprasad T P N. "Bioinformatics Tools for the Discovery of Potential Anti-Diabetic Drugs from Lichens." In Computational Approaches in Biotechnology and Bioinformatics. CRC Press, 2024. http://dx.doi.org/10.1201/9781003354437-10.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Chen, Shyi-Ming, Yun-Hou Huang, Rung-Ching Chen, Szu-Wei Yang, and Tian-Wei Sheu. "Using Fuzzy Reasoning Techniques and the Domain Ontology for Anti-Diabetic Drugs Recommendation." In Intelligent Information and Database Systems. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-28487-8_13.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Thangaraj, Parimelazhagan. "Anti-diabetic Activity." In Progress in Drug Research. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-26811-8_23.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Thangaraj, Parimelazhagan. "Evaluation of Anti-diabetic Property on Streptozotocin-Induced Diabetic Rats." In Progress in Drug Research. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-26811-8_24.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Veni, T., T. Pushpanathan, and G. Vimala. "Plant Constituent as Anti-Cancer Drugs." In Drug Development for Cancer and Diabetes. Apple Academic Press, 2020. http://dx.doi.org/10.1201/9780429330490-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Pal, Sarbani, and Manojit Pal. "Anti-diabetes Research in India: Contributions from Industrial Organizations." In Drug Discovery and Drug Development. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-15-8002-4_8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Mukerji, Geetha, and Denice S. Feig. "Advances in Oral Anti-Diabetes Drugs in Pregnancy." In A Practical Manual of Diabetes in Pregnancy. John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119043805.ch15.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Arch, Jonathan R. S. "Thermogenesis and Related Metabolic Targets in Anti-Diabetic Therapy." In Diabetes - Perspectives in Drug Therapy. Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-17214-4_10.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Mtewa, Andrew G., Duncan Sesaazi, Amanjotannu, and Serawit Deyno. "Essential Drug Properties and Stages in Anti-Cancer Drug Development." In Drug Development for Cancer and Diabetes. Apple Academic Press, 2020. http://dx.doi.org/10.1201/9780429330490-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Anti diabetic drugs"

1

Alkawari, Fatima, Wigdan Ali, Fatiha Benslimane, and Huseyin Yalcin. "Investigating the Cardiac effects of New Generation Anti-Diabetic Drug Empagliflozin using Zebrafish Embryo Model." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0211.

Pełny tekst źródła
Streszczenie:
Type 2 diabetes mellitus (T2DM) affects &gt;16% of adults in Qatar. Newly emerging class of antidiabetic drugs focused on SGLT inhibition were observed to reduce CVDs risks in diabetic patients. Up to date, the mechanism contributing to the CV benefits remains unrevealed. Zebrafish embryos were treated with Aristolochic Acid to induce heart failure then treated with Empagliflozin to determine its beneficial effect. Furthermore the expression of SGLT1 &amp; 2 were determined in the hearts of zebrafish. SGLT2 was expressed more then SGLT1 in the heart and whole embryo. Empa significantly improve
Style APA, Harvard, Vancouver, ISO itp.
2

Chen, Rung-Ching, Cho-Tsan Bau, and Yun-Hou Huang. "Development of anti-diabetic drugs ontology for guideline-based clinical drugs recommend system using OWL and SWRL." In 2010 IEEE International Conference on Fuzzy Systems (FUZZ-IEEE). IEEE, 2010. http://dx.doi.org/10.1109/fuzzy.2010.5584139.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Mujahid, A., I. Haq, T. Hussain, S. Z. Bajwa, and A. Afzal. "P2BM.6 - Tailoring Molecular Imprinted Polymers as Biomimetic Recognition Coatings for Anti-Diabetic Drugs." In 17th International Meeting on Chemical Sensors - IMCS 2018. AMA Service GmbH, Von-Münchhausen-Str. 49, 31515 Wunstorf, Germany, 2018. http://dx.doi.org/10.5162/imcs2018/p2bm.6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Contreras, U., N. Ornelas-Soto, M. A. Meneses-Nava, O. Barbosa-García, P. L. López-de-Alba, and L. López-Martínez. "Rapid screening for quality control and adulteration in anti-diabetic drugs: quantitative and qualitative analysis by LIBS." In Applied Industrial Optics: Spectroscopy, Imaging and Metrology. OSA, 2010. http://dx.doi.org/10.1364/aio.2010.amc3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Loisay, L., S. Bouagga, A. Antoniadis, T. Hügle, and J. Geurts. "POS0794 ANTI-DIABETIC DRUGS TARGET SUBCHONDRAL MARROW ADIPOSE TISSUE METABOLISM IN A PRECLINICAL MODEL OF KNEE OSTEOARTHRITIS." In EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria. BMJ Publishing Group Ltd and European League Against Rheumatism, 2024. http://dx.doi.org/10.1136/annrheumdis-2024-eular.6122.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Nishat, Zurwa, Tara Pellegrino, and Robert Steer. "Outcomes in Type II Diabetes Patients through the Covid 19 Pandemic A Retrospective Chart Review." In 27th Annual Rowan-Virtua Research Day. Rowan University Libraries, 2023. https://doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.54_2023.

Pełny tekst źródła
Streszczenie:
Context: The COVID-19 pandemic provided a unique opportunity for urgent expansion of telemedicine services as providers continued to supply longitudinal care to patients. Patients with type II diabetes were vulnerable to serious infection with COVID-19 as well as disruption in management of their chronic disease. Objective: To delineate the outcomes in type II diabetes patients through the COVID-19 pandemic by a retrospective chart review in which disease management was evaluated through HbA1c levels and BMI. Methods: This retrospective chart review included adult T2DM patients receiving care
Style APA, Harvard, Vancouver, ISO itp.
7

Carvalho, Ana Cláudia Pires, Fernanda Rezende Dias, Luisa Crevelin Costa, and Natália de Castro Fim Nakao. "Myopathy following statin use." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.512.

Pełny tekst źródła
Streszczenie:
Introduction: Myopathies can be caused by various drugs, including statins and corticosteroids, and can be toxic or inflammatory, one example being necrotizing myositis triggered by statins. Objectives: Describe the case of a patient with weakness after statin use. Design and setting: Case report Methods: Analysis of medical record, photographic record of the diagnostic methods and literature review. Case description: 69-year-old female, obese, hypertensive, diabetic, dyslipidemic and hypothyroid, taking atorvastatin since 2017, referred by endocrinology for generalized myalgia in 2019, with i
Style APA, Harvard, Vancouver, ISO itp.
8

Jakhotia, Sneha, Branislav Nastasijević, Gordana Joksić, Sreenivasa Reddy, and G. Bhanuprakash Reddy. "Gentiana lutea AND DIABETIC COMPLICATIONS." In 8th Workshop Food and Drug Safety and Qualit. Vinča Institute of Nuclear Sciences - National Institute of the Republic of Serbia, 2024. http://dx.doi.org/10.46793/8fdsq.ild1sj.

Pełny tekst źródła
Streszczenie:
Chronic hyperglycemia in diabetes leads to macro and microvascular complications. An increase in the aldose reductase (ALR2) activity, accumulation of sorbitol, accumulation of advanced glycation end-products (AGEs), and inflammation lead to cellular damage, ultimately resulting in complications. ALR2 inhibition has been a consideration to treat/manage diabetic complications, but most of the ALR2 inhibitors are not free of side effects. As a part of our work to find better ALR2 inhibitors, we found that extracts of Gentiana lutea exhibited ALR2 inhibitory potential in vitro. We have also disco
Style APA, Harvard, Vancouver, ISO itp.
9

Falabella, Petra, and Željka Večerić-Haler. "Arginine Vasopressin Resistance (AVP-R)." In Socratic Lectures 11. University of Lubljana Press, 2024. http://dx.doi.org/10.55295/psl.11.2024.1.

Pełny tekst źródła
Streszczenie:
Arginine vasopressin resistance (AVP-R) previously known as nephrogenic diabetes insipidus is a rare disorder characterised with large fluid output due to resistance to arginine vasopressin in kidneys. It can be caused by different etiologies, including hereditary causes. In diagnosis we must determine the reason for polyuria (vasopressin deficiency, resistance, or primary polydipsia). Treatment is mostly symptomatic with adequate water consumption in combination with low-salt and low-protein diet. The main drugs used to treat AVP-R are thiazide diuretics, non-steroidal anti-inflammatory drugs
Style APA, Harvard, Vancouver, ISO itp.
10

Christopher, Devasahayam Jesudas, Deva Jedidiah, Barney Isaac, Binu Mathew, and Blessed Winston. "Anti-tubercular drug concentrations in Pulmonary Tuberculosis patients - Diabetic vs Non-Diabetic groups." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa2999.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Anti diabetic drugs"

1

Jin, Dachuan, Gao Peng, Shunqin Jin, Tao Zhou, Baoqiang Guo, and Guangming Li. Comparison of therapeutic effects of anti-diabetic drugs on non-alcoholic fatty liver disease patients without diabetes: A network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.11.0014.

Pełny tekst źródła
Streszczenie:
Review question / Objective: To evaluate the efficacy of different anti-diabetic drugs in the treatment of non-diabetic non-alcoholic disease by network meta-analysis, and find the best intervention. Condition being studied: Non-alcoholic fatty liver disease (NAFLD) refers to the disease in which the liver fat content exceeds 5%, and excludes the secondary causes of alcohol, infection, drugs or other specific metabolic diseases. As a spectrum of disorders, it includes hepatocyte steatosis and steatohepatitis at the initial stage, liver fibrosis at the later stage, cirrhosis at the final stage,
Style APA, Harvard, Vancouver, ISO itp.
2

Jiang, Yang, Wei He, and Shi-xin Qi. Evaluating the efficacy of subthreshold micropulse laser combined with anti-VEGF drugs in the treatment of diabetic macular edema: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. https://doi.org/10.37766/inplasy2024.12.0068.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Piao, Tianhua, Hongyang Ma, and Rui Wang. Comparison Between Ozurdex and TA as An Adjunct Drug Combined with Intravitreal anti-VEGF Treatment for Diabetic Macular Edema: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.6.0027.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!